Michigan medtech company raises $77M for renal denervation solution to hypertension
January 04, 2019 / KEVIN TRUONG
Hypertension is a condition that affects millions of people around the world and can lead to serious health issues including cardiac arrest, stroke and heart failure. It also represents a significant burden and cost to the healthcare system as a whole. One potential innovative pathway to addressing hypertension outside of traditional medication is through a process known as renal denervation, where nerves in the renal system are targeted to reduce blood pressure.